Last reviewed · How we verify

NCT07137572: AoP-II

Arts-based Social Prescribing for Mental Health

Completed NA Last updated 18 March 2026
What this trial tests

NA trial testing Art Prescription in Mental Health Issue in 541 participants. Completed in 25 February 2026.

Timeline
4 September 2025
Primary endpoint
25 February 2026
25 February 2026

Quick facts

Lead sponsorKAVADIA ELENI
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment541
Start date4 September 2025
Primary completion25 February 2026
Estimated completion25 February 2026
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

KAVADIA ELENI

Who can join

18 and older, any sex, with Mental Health Issue or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a parallel-group randomised-controlled trial aiming to assess the effect of exposure to the arts on mental health and wellbeing of community dwelling recipients of mental health care. The trial constitutes a comparison of two arms: An Art Intervention arm, hereby the Active Group (AG), versus a waitlist control arm (WL).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mental Health Issue

Currently open trials in the same condition.

Other KAVADIA ELENI trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07137572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing